Last updated: May 5, 2026
AU2024309346 in Australia: Scope, Claim Coverage, and Patent Landscape
What is AU2024309346 and what does it cover?
AU2024309346 is a published Australian patent application (publication number format: AU2024309346). The available information needed to deliver a complete, claim-by-claim scope analysis (exact title, specification summary, independent claim set, claim numbering, and full text) is not present in the inputs provided in this chat. Without the patent document text (or a reliable extract), a precise determination of claim scope, claim dependencies, therapeutic coverage, composition/compound breadth, formulation scope, and method-of-use boundaries cannot be produced accurately.
What are the key claim elements and how broad is the coverage?
A claim-scope analysis requires the actual claim language. The following elements cannot be determined without the application claims:
- Independent claim structure (e.g., compound, composition, method, use)
- Claim breadth drivers
- genus vs individual compounds
- Markush limitations vs open ranges
- defined salts/polymorphs vs broad “pharmaceutically acceptable” wording
- formulation parameter thresholds (particle size, pH, excipients)
- dosing regimens (mg/kg/day ranges, interval constraints)
- Dependency web (what narrower features each dependent claim adds)
- Exclusions or carve-outs (therapeutic indications, existing therapies, prior art amendments)
- Construction of claim terms (defined terms, reference to descriptions, claim charts)
How does AU2024309346 fit into the Australian patent landscape (drug-specific coverage)?
A landscape-level assessment requires at least one of the following, all of which depend on document text or database retrieval:
- linked international family members (WO/EP/US filings) for claim reconciliation
- identified compound identifiers (IUPAC, generic name, CAS)
- known assignee(s) and prosecution history signals (continuations, divisionals)
- co-existing filings in Australia on:
- the same compound class
- the same formulation platform
- the same indication (therapeutic use)
None of these facts can be established from the information currently available in this chat.
What does the landscape imply for freedom to operate (FTO) in Australia?
An FTO-oriented patent landscape depends on determining:
- whether AU2024309346 is a primary blocking patent (composition or compound claims)
- whether it is a secondary patent (formulation/process/combination therapy)
- whether it overlaps with:
- earlier compound patents that block generics
- later formulation or use patents that block specific dosage forms
- combination patents that block co-administered regimens
- whether any relevant Australian patents are likely to be enforceable given:
- term/expiry positioning
- prior art status at grant or acceptance
- scope narrowing during examination
Because the claim content and family relationships are not available here, any FTO conclusion would be speculative.
Bottom-line: what can be stated with precision from the provided inputs?
- AU2024309346 is identified only by its Australian application number in the prompt.
- A complete and accurate scope and claims analysis is not possible without the actual claim text and specification details.
- A proper patent landscape also requires family and claim-to-asset mapping, which cannot be performed with only the application number.
Key Takeaways
- AU2024309346 cannot be analyzed for scope, claim coverage, or landscape position using only the application number provided.
- A defensible patent-claim and landscape assessment requires the exact claim language and associated family/document data.
FAQs
- Can AU2024309346 be evaluated for claim breadth without the claim text? No. Claim scope and term construction require the exact claim language.
- How is an AU drug patent landscape typically built in Australia? By mapping compound/composition/use claims across Australian family members and then checking overlap with earlier and later filings.
- What determines whether a patent blocks generics in Australia? The presence of enforceable composition or method-of-use claims that cover the generic product’s active ingredient and/or claimed regimen.
- Does Australian application publication equal immediate enforceability? Publication is not the same as enforceable right; enforceability depends on grant and claim status.
- What’s the fastest way to do a rigorous AU landscape for a single application? Extract the application’s claims and identify its family to map directly to overlapping Australian filings.
References
[1] Australian Government IP Australia. “Australian patent search and register (Patents Online).” https://search.ipaustralia.gov.au/patents
[2] World Intellectual Property Organization (WIPO). PATENTSCOPE (for WO-family retrieval). https://patentscope.wipo.int
